[HTML][HTML] Cost-effectiveness analysis alongside clinical trials II—an ISPOR Good Research Practices Task Force report

SD Ramsey, RJ Willke, H Glick, SD Reed… - Value in health, 2015 - Elsevier
Clinical trials evaluating medicines, medical devices, and procedures now commonly
assess the economic value of these interventions. The growing number of prospective …

Handling uncertainty in cost-effectiveness models

AH Briggs - Pharmacoeconomics, 2000 - Springer
The use of modelling in economic evaluation is widespread, and it most often involves
synthesising data from a number of sources. However, even when economic evaluations are …

[책][B] Bayesian approaches to clinical trials and health-care evaluation

DJ Spiegelhalter, KR Abrams, JP Myles - 2004 - books.google.com
READ ALL ABOUT IT! David Spiegelhalter has recently joined the ranks of Isaac Newton,
Charles Darwin and Stephen Hawking by becoming a fellow of the Royal Society …

Representing uncertainty: the role of cost‐effectiveness acceptability curves

E Fenwick, K Claxton, M Sculpher - Health economics, 2001 - Wiley Online Library
Decision‐making in health care is inevitably undertaken in a context of uncertainty
concerning the effectiveness and costs of health care interventions and programmes. One …

Cost‐effectiveness acceptability curves–facts, fallacies and frequently asked questions

E Fenwick, BJ O'Brien, A Briggs - Health economics, 2004 - Wiley Online Library
Cost‐effectiveness acceptability curves (CEACs) have been widely adopted as a method to
quantify and graphically represent uncertainty in economic evaluation studies of health‐care …

Generalized cost-effectiveness analysis for national-level priority-setting in the health sector

R Hutubessy, D Chisholm, TTT Edejer… - Cost effectiveness and …, 2003 - Springer
Cost-effectiveness analysis (CEA) is potentially an important aid to public health decision-
making but, with some notable exceptions, its use and impact at the level of individual …

Good research practices for cost‐effectiveness analysis alongside clinical trials: the ISPOR RCT‐CEA Task Force report

S Ramsey, R Willke, A Briggs, R Brown… - Value in …, 2005 - Wiley Online Library
Objectives: A growing number of prospective clinical trials include economic end points.
Recognizing the variation in methodology and reporting of these studies, the International …

GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence

M Brunetti, I Shemilt, S Pregno, L Vale… - Journal of clinical …, 2013 - Elsevier
OBJECTIVES: In this article, we describe how to include considerations about resource
utilization when making recommendations according to the Grading of Recommendations …

A guide to cost-effectiveness acceptability curves

E Fenwick, S Byford - The British Journal of Psychiatry, 2005 - cambridge.org
Use of cost-effectiveness acceptability curves, as a method for summarising information on
uncertainty cost-effectiveness, has become widespread within applied studies. This includes …

Modelling in the economic evaluation of health care: selecting the appropriate approach

P Barton, S Bryan, S Robinson - Journal of health services …, 2004 - journals.sagepub.com
Objectives: To provide an overview of alternative approaches to modelling in economic
evaluation, and to highlight situations where each of the alternative modelling techniques …